DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling
Drug Design, Development and Therapy · 2025-07 · Volume 19 · 6469-6485
DOI: 10.2147/dddt.s530823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-07. Verfasst von Hua Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Gastrointestinal Microbiome, Diabetic Nephropathies, Receptors, Cytoplasmic and Nuclear. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China.
- Department of Nephrology, The Second People's Hospital of Hefei, Hefei, 230011, People's Republic of China.
- Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China.
- Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China.
- Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China.
- Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People's Republic of China.
Zitieren
APA
Zhou, H., Mu, X., Hu, H., Zhao, S., Hu, N., Yang, M., & Jiang, J. (2025). DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling. Drug Design, Development and Therapy, Volume 19, 6469-6485. https://doi.org/10.2147/dddt.s530823
Vancouver
Zhou H, Mu X, Hu H, Zhao S, Hu N, Yang M, et al. DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling. Drug Design, Development and Therapy. 2025;Volume 19:6469-6485. doi:10.2147/dddt.s530823
BibTeX
@article{Zhou2025,
author = {Zhou, Hua and Mu, Xiaodie and Hu, Huiyue and Zhao, Shuya and Hu, Nan and Yang, Min and Jiang, Jingting},
title = {DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {6469--6485},
doi = {10.2147/dddt.s530823}
}
EUVIMED